Literature DB >> 350347

Relative chloroquine resistance of P falciparum in Zambia.

A A Khan, M J Maguire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 350347      PMCID： PMC1605473          DOI： 10.1136/bmj.1.6128.1669

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

Review 1.  Chemoprophylaxis of malaria in Africa: the spent "magic bullet".

Authors:  L J Bruce-Chwatt
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11

2.  Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. 1. Results of in vivo and in vitro studies and of an ophthalmological survey.

Authors:  E Onori; D Payne; D Grab; B Grab; H I Horst; J Almeida Franco; H Joia
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

3.  Suspected chloroquine-resistant malaria in Nigeria.

Authors:  A G Rivett
Journal:  Br Med J       Date:  1980-07-19

4.  [A case of chloroquine-resistant (R1) falciparum malaria from the East African Comoros Islands (author's transl)].

Authors:  D Eichenlaub; H D Pohle
Journal:  Infection       Date:  1980       Impact factor: 3.553

5.  The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara.

Authors:  E Onori
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

6.  Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola.

Authors:  Cláudia Fançony; Dina Gamboa; Yuri Sebastião; Rachel Hallett; Colin Sutherland; José Carlos Sousa-Figueiredo; Susana Vaz Nery
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

7.  Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.

Authors:  Michael Nambozi; Jean-Pierre Van Geertruyden; Sebastian Hachizovu; Mike Chaponda; Doreen Mukwamataba; Modest Mulenga; David Ubben; Umberto D'Alessandro
Journal:  Malar J       Date:  2011-02-28       Impact factor: 2.979
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.